Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Head and Neck Neoplasms 4Small Cell Lung Carcinoma 3Lymphoma, Extranodal NK-T-Cell 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Uterine Cervical Neoplasms 1Squamous Non-small-cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Non-Small Cell Lung Cancer Metastatic 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Locally Advanced Malignant Neoplasm 1Intracranial Germ Cell Tumors 1Carcinoma, Squamous Cell 1Cancer Therapy-related Cardiovascular Toxicity 1Biliary Tract Neoplasms 1Anemia 1Adenocarcinoma of Lung 1

Interventions

VAP-cyclo protocol 2Gemcitabine 2apatinib 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Lenalidomide 1Ifosfamide 1Etoposide 1Dexamethasone 1Cisplatin 1Asparaginase 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, T-Cell, Peripheral × Cisplatin × Clear all
NCT03071822 2018-06-11

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

The University of Hong Kong

Phase 4 Unknown
50 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡